NCT01832298 - Study of Simmitecan Hydrochloride in the Treatment of Advanced Solid Tumor | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

March 31, 2016

Study Completion Date

August 31, 2016

Conditions

Advanced Solid Tumor

Interventions

DRUG

Simmitecan Hydrochloride for Injection

Either at 12.5 mg, 25 mg、50 mg、80 mg、120 mg、160 mg、200 mg

Trial Locations (3)

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

The tumor hospital affiliated to Harbin medical university, Harbin

West China Hospital, Sichuan University, Chengdu